The potential of H5N1 viruses to adapt to bovine cells varies throughout evolution
- PMID: 41398153
- PMCID: PMC12706089
- DOI: 10.1038/s41467-025-67234-1
The potential of H5N1 viruses to adapt to bovine cells varies throughout evolution
Abstract
Avian influenza H5N1 clade 2.3.4.4b viruses caused a global panzootic and, unexpectedly, widespread outbreaks in dairy cattle, therefore representing a pandemic threat. To inform control strategies, it is critical to determine whether the potential to adapt to bovine cells is a general feature of H5N1 viruses, is specific to viruses of clade 2.3.4.4b, or narrowly restricted to some genotypes within this clade. Using a large panel of recombinant viruses representing >60 years of H5N1 history and other IAVs for comparison, we demonstrate replicative fitness in bovine cells is: (i) highly variable across 2.3.4.4b genotypes, (ii) limited in viruses predating the global expansion of this clade, (iii) determined by the internal gene cassette, and (iv) not restricted to udder epithelial cells. Mutations in the PB2 polymerase subunit emerge as key determinants of adaptation, although their phenotypic effects are context dependent. Bovine B3.13 and some avian genotypes exhibit enhanced modulation of bovine interferon-induced antiviral responses, determined by at least PB2, nucleoprotein, and the non-structural protein NS1. Our results highlight the polygenic nature of IAV host range, and reveal that the replication fitness in bovine cells, and likely their potential to adapt to cattle, varies greatly during the evolutionary trajectory of H5N1 viruses.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
MeSH terms
Substances
Grants and funding
- BB/V004697/1/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
- MC_UU_00034/5/RCUK | Medical Research Council (MRC)
- MR/Y004205/RCUK | Medical Research Council (MRC)
- 226141/Z/22/Z/Wellcome Trust (Wellcome)
- 101102733/EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology)
- MR/Y03368X/1/RCUK | Medical Research Council (MRC)
- A1920/Cancer Research UK (CRUK)
- MC_UU_00034/3/RCUK | Medical Research Council (MRC)
- BB/Y007298/1/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
- 218518/Z/19/Z/Wellcome Trust (Wellcome)
- WT_/Wellcome Trust/United Kingdom
- MC_UU_00034/9/RCUK | Medical Research Council (MRC)
- BBS/E/PI/230002B/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
- BBS/E/PI/230001B/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
- A31287/Cancer Research UK (CRUK)
- MC_UU_0034/5/RCUK | Medical Research Council (MRC)
- BBS/E/PI/23NB0003/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
LinkOut - more resources
Full Text Sources
Medical
